SCHEMBL868802

SCHEMBL868802

C[C@H](c1ccccc1)N1CC2(C)CC2(OC(=O)N(C)C(C)(C)C)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.35
OPRK1 P41145 2/20 0.34
OPRL1 P41146 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ACHE P22303 1/20 0.33
ATM Q13315 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MC4R P32245 1/20 0.33
BRD4 O60885 1/20 0.32
TAF1 P21675 1/20 0.32
CECR2 Q9BXF3 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2636381 0.81 CYP2D6 (0.41) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL2636383 0.81 CYP2D6 (0.41) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL869078 0.81 CYP2D6 (0.36) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL10027444 0.73 CYP2D6 (0.35) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL10027443 0.68 CTSK (0.37) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL4748443 0.65 OPRL1 (0.37) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL2670195 0.65 OPRL1 (0.37) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL3296151 0.65 OPRL1 (0.42) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL10565433 0.65 CYP2D6 (0.55) CYP2D6OPRK1OPRL1OPRM1OPRD1
SCHEMBL868771 0.64 CYP2D6 (0.50) CYP2D6OPRK1OPRL1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077795-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS GLAXSMITHKLINE LLC (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077795-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS MCHR1, MCHR2, MC1R CYP2D6 557/4885OPRK1 85/4885OPRL1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.